Elliott D. Kozin

Elliott D. Kozin

Auto-generated profile, based on publicly available information

Elliott D. Kozin

From the Department of Radiology (M.P., A.F.J., H.D.C., L.V.R., K.L.R.), Otolaryngology (J.O., D.E.A.-A., A.M.Q., E.D.K., D.H.J.), Massachusetts Eye and Ear, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2008 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
JFJ. Raymond Fitzpatrick
J. Raymond Fitzpatrick
JFJohn R. Frederick
John R. Frederick
VHVivian M. Hsu
Vivian M. Hsu
EKElliott D. Kozin
Elliott D. Kozin
MOMary Lou O'HAra
Mary Lou O'HAra
YWY. Joseph Woo
Y. Joseph Woo

1 April 2009 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
JFJ. Raymond Fitzpatrick
J. Raymond Fitzpatrick
JFJohn R. Frederick
John R. Frederick
WHWilliam Hiesinger
William Hiesinger
VHVivian M. Hsu
Vivian M. Hsu
RMRyan C. McCormick
Ryan C. McCormick
YWY. Joseph Woo
Y. Joseph Woo

1 April 2013 in Current Biology
Verified
Journal Article
Closed access
SESeham Ebrahim
Seham Ebrahim
TFTomoki Fujita
Tomoki Fujita
BMBryan A. Millis
Bryan A. Millis
EKElliott Kozin
Elliott Kozin
XMXuefei Ma
Xuefei Ma
BKBechara Kachar
Bechara Kachar

5 January 2012 in Blood
Verified
Journal Article
Open access
PDF file
YZYingfan Zhang
Yingfan Zhang
MCMary Anne Conti
Mary Anne Conti
DMDaniela Malide
Daniela Malide
FDFan Dong
Fan Dong
AWAibing Wang
Aibing Wang
RARobert S. Adelstein
Robert S. Adelstein
We have generated 3 mouse lines, each with a different mutation in the nonmuscle myosin II-A gene, Myh9 (R702C, D1424N, and E1841K). Each line develops MYH9-related disease similar to that found in human patients. R702C mutant human cDNA fused with green fluorescent protein was introduced into the first coding exon of Myh9, and D1424N and E1841K mutations were introduced directly into the corresponding exons. Homozygous R702C mice die at embryonic day 10.5-11.5, whereas homozygous D1424N and E1841K mice are viable. All heterozygous and homozygous mutant mice show macrothrombocytopenia with prolonged bleeding times, a defect in clot retraction, and increased extramedullary megakaryocytes. Studies of cultured megakaryocytes and live-cell imaging of megakaryocytes in the BM show that heterozygous R702C megakaryocytes form fewer and shorter proplatelets with less branching and larger buds. The results indicate that disrupted proplatelet formation contributes to the macrothrombocytopenia in mice and most probably in humans. We also observed premature cataract formation, kidney abnormalities, including albuminuria, focal segmental glomerulosclerosis and progressive kidney disease, and mild hearing loss. Our results show that heterozygous mice with mutations in the myosin motor or filament-forming domain manifest similar hematologic, eye, and kidney phenotypes to humans with MYH9-related disease.

24 November 2014 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
EKElliott D. Kozin
Elliott D. Kozin
SGShawn Gulati
Shawn Gulati
AKAlyson B. Kaplan
Alyson B. Kaplan
ALAshton E. Lehmann
Ashton E. Lehmann
ARAaron K. Remenschneider
Aaron K. Remenschneider
DLDaniel J. Lee
Daniel J. Lee

18 June 2013 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
RSRoshan Sethi
Roshan Sethi
EKElliott Kozin
Elliott Kozin
ARAaron Remenschneider
Aaron Remenschneider
JMJosh Meier
Josh Meier
Paul VanderLaanPaul VanderLaan
Paul VanderLaan
RFRobert Frankenthaler
Robert Frankenthaler